JB Chemicals and Pharmaceuticals Ltd. on Friday said it has received approval from the US health regulator to market a generic medication to treat high blood pressure.
The company has received approval from the US Food and Drug Administration for Bisoprolol tablets in strengths of 5 mg and 10 mg, the company said in a regulatory filing.
The company's product is the generic version of Teva's Zebeta tablets, which are indicated for the management of hypertension.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
MP Cough Syrup Deaths: Maharashtra FDA Orders Inspection Of Liquid Oral Formulations
Biocon Unit Gets USFDA Nod For Generic Rifaximin Tablets Used To Treat IBS-D
Alembic Pharma Gets USFDA Nod For Generic Drug To Treat Depression, Anxiety
Lupin Gets USFDA Nod For Generic Risperidone Extended-Release Injectable Suspension
POPULAR
1
'Building Block For More Startups': Vivek Oberoi Reflects On Experience As University Co-Founder
2
Adani Energy Q2 Business Update: Collection Efficiency Doubles, Transmission Network Increases
3
Adani Green Talks Ep 2: Innovating For The Environment And Disability Inclusion
4
'Decisive Support To Our Cause': Nobel Peace Prize Winner Dedicates Award To Donald Trump
5